OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 6.35
+0.49 (8.36%)
Mar 4, 2026, 3:23 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 89.21 million as of March 4, 2026. Its market cap has increased by 49.62% in one year.
Market Cap
89.21M
Enterprise Value
92.99M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.35
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has increased from 89.02M to 89.21M, an increase of 0.21%. That is a compound annual growth rate of 0.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 82.32M | -3.71% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 128.23M |
| Xbrane Biopharma AB | 127.86M |
| Active Biotech AB | 126.53M |
| Biovica International AB | 105.09M |
| Annexin Pharmaceuticals AB | 103.06M |
| Alligator Bioscience AB | 102.73M |
| Biosergen AB | 90.17M |
| Scandinavian ChemoTech AB | 89.09M |